- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03569176
Examining the Efficacy of a Mobile Therapy for Children With Autism Spectrum Disorder
July 16, 2018 updated by: Dennis Paul Wall
Superpower Glass Project: A Mobile At-home Intervention for Children With Autism
The purpose of this research is to study the effects of a novel artificial intelligence (AI) tool for automatic facial expression recognition that runs on Google Glass through an Android app to deliver social emotion cues to children with autism during social interactions.
This novel device will use a camera, microphone, head motion tracker to analyze the behavior of the subject during interactions with other people.
The system is designed to give participants non-interruptive social cues in real-time and will record social responses that can later be used to help aid behavioral therapy.
It is hypothesized that the system's ability to provide continuous behavioral therapy during social interactions will enable faster gains in social skills.
Study Overview
Study Type
Interventional
Enrollment (Actual)
74
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 12 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- the child has been diagnosed professionally with ASD
- the child is currently receiving ABA therapy at least twice per week at home.
- The child's family is willing to drive to Stanford University for up to 4 study appointments.
Exclusion Criteria:
- The child scores less than 15 on the Social Communication Questionnaire
- The child's family does not speak English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Autism Glass Intervention
Participants in the experimental group will receive the autism glass for 6 weeks once they are assigned to the experimental condition.
Participants will be asked to use the glasses at least 3 times a week for 20 minutes sessions in addition to continuing Applied Behavior Analysis (ABA) therapy.
|
The intervention uses the outward-facing camera on the google glasses to read facial expressions and provides social cues within the child's natural environment during usual social interaction and during games accessed via the smartphone application.
Participants who receive the Google Glass intervention will be asked to use it for around 20 minutes 3 times a week with their parents or during ABA therapy.
|
OTHER: Crossover Control for Autism Glass
Participants randomized to the control arm, will continue treatment as usual (receiving ABA twice a week) while the intervention participants will receive the Autism Glass intervention (while continuing to receive ABA therapy).
After 6 weeks, control participants will receive the Autism Glass intervention after which, they will be asked to come in for a second round of follow-up testing following 6 weeks of use (at week 18).
|
The intervention uses the outward-facing camera on the google glasses to read facial expressions and provides social cues within the child's natural environment during usual social interaction and during games accessed via the smartphone application.
Participants who receive the Google Glass intervention will be asked to use it for around 20 minutes 3 times a week with their parents or during ABA therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in socialization subscale scores of the Vineland Adaptive Behavior Scales, 2nd Edition (VABS-II) from baseline to week 6.
Time Frame: Baseline (week 0), Week 6
|
Vineland Adaptive Behavior Scales, 2nd edition (VABS-II) Socialization subscale will be conducted at the university by a trained research team member.
Scores from the socialization domain of the VABS-II reflects one's functioning in social situations.
The socialization subscale is 32 items, where raw scores are converted to IQ-type standard scores (mean: 100 sd: 15) for each domain and for the composite adaptive behavior score.
|
Baseline (week 0), Week 6
|
Change in Parent Rated Social Responsiveness Scale 2 (SRS-2) from baseline to week 6
Time Frame: Baseline (week 0), Week 6
|
The SRS-2 is a 65-item measure where parents rate their child selecting responses on a Likert Scale.
This measure will be used to measure and identify social impairment associated with Autism Spectrum Disorder (ASD) and to quantify its severity.
|
Baseline (week 0), Week 6
|
Change in NEPSY-II, Affect Recognition subscale scores from baseline to week 6
Time Frame: Baseline (week 0), Week 6
|
The NEPSY-II Affect Recognition subdomain assesses a child's social perception of facial affect recognition.
It is designed to assess a child's ability to recognize 6 emotions (happy, sad, angry, fear, disgust, and neutral) from colored photographs of children's faces in four different tasks.
|
Baseline (week 0), Week 6
|
Change in Emotion Guessing Game (EGG) scores from baseline to week 6
Time Frame: Baseline (week 0), Week 6
|
The Emotion Guessing Game is a novel test created for purposes of this study to evaluate the child's ability to correctly label emotions expressed by an examiner in real time.
EGG is a pre-set list of 8 emotions, listed 5 times each (Happy, Sad, Angry, Afraid, Surprised, Calm, Disgust, and "Meh"/contempt).
During the quick 40-question evaluation, the research coordinator first lists the various emotion choices to the child before beginning the evaluation.
Then, the examiner acts out each emotion listed, in order, and waits for a guess from the child, who labels the emotion.
The EGG is scored by summing the number of correct responses from the child.
|
Baseline (week 0), Week 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in ASD symptoms as measured by Brief Observation of Social Communication Change (BOSCC) from baseline to week 6
Time Frame: Baseline (week 0), week 6
|
The Brief Observation of Social Communication Change (BOSCC) is designed to measure change in core symptoms of children with autism.
It aims to capture change in social communication, interaction, and eye contact.
The BOSCC is a play based assessment that consists of two boxes filled with specific toys and takes about 12 minutes to complete.
|
Baseline (week 0), week 6
|
Change in adaptive social and personal skills as measured by Vineland Adaptive Behavior Scales, 2nd edition (VABS-II) Full Scale from baseline to week 6.
Time Frame: Baseline (week 0), week 6
|
The VABS-II is a robust and comprehensive measure of personal and social skills needed in everyday living.
The VABS-II covers a child's conceptual, social, and practical skills and can assess children from birth to 90 years.
The parent can complete the entire questionnaire in about 20-30 minutes.
|
Baseline (week 0), week 6
|
Change in child's emotional, behavioral, and social problems from Baseline (week 0) to Week 6 as measured by Child Behavior Checklist (CBCL).
Time Frame: Baseline (week 0), Week 6
|
The CBCL is a caregiver-directed report that identifies emotional, behavioral, and social problems in children.
It is a 20 item measure completed by parents.
|
Baseline (week 0), Week 6
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stanford-Binet Intelligence Scales, Abbreviated Battery, Fifth Edition (ABIQ) score at baseline
Time Frame: Baseline (week 0)
|
The ABIQ assessment measures a child's IQ based on an abbreviated (10 minute) task that measures Nonverbal Fluid Reasoning and Verbal Knowledge to create a standard score for IQ.
It will be completed for each child during Intake.
|
Baseline (week 0)
|
Mobilized Machine Learning Autism Risk Assessment (MARA) score of autism severity at baseline
Time Frame: Baseline (week 0)
|
The MARA screens for, quantifies, and tracks the severity of core autism symptoms.
Parents respond to the survey and it takes less than 5 minutes to complete.
The core behavioral domains the MARA focuses on are communication, social reciprocity, and restricted, repetitive, and stereotyped behaviors.
Each response to a question is run through a machine learning model that uses an alternating decision tree algorithm to generate a total score ranging from most severe, -10 to least severe, 7.
|
Baseline (week 0)
|
Social Communication Questionnaire (SCQ) score at baseline
Time Frame: Baseline (week 0)
|
The social communication questionnaire (SCQ) screens for autism in children over 4:0 years in age.
Parents are asked 40 Yes/No questions and the resulting score is out of 39 (the first question is not associated with a numerical value).
The SCQ assesses a child's communication skills and social functioning.
It takes less than 10 minutes to complete and is administered by clinical research coordinators to parents of children during the phone screen to participants who have already completed the online screening questionnaire.
A score of 15 or above is indicative of autism and is required to be eligible in the research study.
|
Baseline (week 0)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 1, 2016
Primary Completion (ACTUAL)
April 11, 2018
Study Completion (ACTUAL)
April 15, 2018
Study Registration Dates
First Submitted
June 14, 2018
First Submitted That Met QC Criteria
June 14, 2018
First Posted (ACTUAL)
June 26, 2018
Study Record Updates
Last Update Posted (ACTUAL)
July 17, 2018
Last Update Submitted That Met QC Criteria
July 16, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-34059
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Autism Glass
-
Oregon Health and Science UniversityBoston Medical Center; Providence Health & ServicesActive, not recruitingAutism Spectrum DisorderUnited States
-
Florida State UniversityNational Institute of Mental Health (NIMH); Emory University; Weill Medical College... and other collaboratorsCompletedAutism Spectrum DisorderUnited States
-
Oregon Health and Science UniversityProvidence Health & ServicesActive, not recruiting
-
The University of Texas at DallasTerminatedAutism Spectrum Disorder | Typical DevelopmentUnited States
-
Fondation LenvalCompletedAutism Spectrum DisorderFrance
-
Vanderbilt UniversityNorthwestern UniversityCompleted
-
Örebro County CouncilÖrebro University, SwedenCompletedAutism Spectrum DisorderSweden
-
Hôpital le VinatierCompleted
-
University Hospitals Cleveland Medical CenterCompletedAutism Spectrum DisorderUnited States